COMMUNIQUÉS West-GlobeNewswire

-
Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations
13/02/2019 -
Natus Medical Announces Fourth Quarter and Full Year 2018 Financial Results
13/02/2019 -
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
13/02/2019 -
Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results
13/02/2019 -
Natus Medical Announces Continued Board Refreshment with Two New Independent Directors
13/02/2019 -
AroCell's CEO share his views on the company in a video interview
13/02/2019 -
Sensorion to Present New SENS-401 Data at ARO 2019 MidWinter Meeting, Feb. 9-13, 2019
13/02/2019 -
PCI Biotech: Fourth quarter and preliminary 2018 results
13/02/2019 -
ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology
13/02/2019 -
MacroGenics Announces Pricing of Public Offering of Common Stock
13/02/2019 -
Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2019 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/02/2019 -
Tabula Rasa HealthCare Announces Closing of Offering of 1.75% Convertible Notes and Exercise in Full of Option to Purchase Additional Notes
12/02/2019 -
National Research Corporation Announces Fourth Quarter and Year-End 2018 Results
12/02/2019 -
Medexus inscrit les débentures convertibles non garanties d’octobre 2018 à la Bourse de croissance TSX
12/02/2019 -
VistaGen Therapeutics Reports Fiscal 2019 Third Quarter Financial Results
12/02/2019 -
NextGen Healthcare and Veradigm™ Team to Improve Connectivity and Data Exchange with Payers & Labs
12/02/2019 -
Retrophin to Report Fourth Quarter and Full Year 2018 Financial Results
12/02/2019 -
Precision Optics Corporation, Inc. Announces Operating Results for the Second Quarter and Six Months of Fiscal Year 2019
12/02/2019
Pages